ConductScience.org, home

Library / Genes

ARID1A: AT-rich interaction domain 1A

1 protein, 57 patents, 0 drugs, 0 trials, 4,012 NIH grants and 9,879 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolARID1AHGNC
NameAT-rich interaction domain 1AHGNC
NCBI Gene ID8289NCBI Gene
HGNC IDHGNC:11110HGNC
EnsemblENSG00000117713NCBI Gene
AliasesB120, BAF250, BAF250a, BM029, C10rf4, C1orf4, CSS2, ELD, MRD14, OSA1, P270, SMARCF1, hELD, hOSA1NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
O14497AT-rich interactive domain-containing protein 1A2,2857Ensembl, GeneID, HGNCUniProt

Patents 57

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
EP 4650780 A22025-11-195314O14497Espacenet
JP 2025164846 A2025-10-3012O14497Espacenet
EP 4641201 A22025-10-294906O14497Espacenet
JP 2025147176 A2025-10-0614744O14497Espacenet
JP 2025517969 A2025-06-124906O14497Espacenet
JP 2025517970 A2025-06-125314O14497Espacenet
JP 2025062604 A2025-04-146802O14497Espacenet
JP 2025028160 A2025-02-2814744O14497Espacenet
KR 1020250010750 A2025-01-2114744O14497Espacenet
US 12162865 B22024-12-109O14497Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 4012

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant3092,025NIH's project files
P30CA016672Cancer Center Support Grant1732,025NIH's project files
P30CA006973Regional Oncology Research Center442,025NIH's project files
P30CA010815Consolidated Basic Cancer Research Program292,025NIH's project files
P30CA015083Mayo Clinic Comprehensive Cancer Center Support Grant262,025NIH's project files
P30CA014089University of Southern California Norris Comprehensive Cancer Center Support Grant (CCSG)252,025NIH's project files
P30CA016086Cancer Center Support Grant252,025NIH's project files
UL1TR001863Yale Clinical and Translational Science Award252,025NIH's project files
P50CA136393Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancer212,025NIH's project files
R01CA202919Mechanistic basis and therapeutic strategies for ARID1A mutation in ovarian cancer212,025NIH's project files

Papers 9879

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42819154PubTator, text miningPubMed
42817222PubTator, text miningPubMed
42804804PubTator, text miningPubMed
42795000PubTator, text miningPubMed
42793688PubTator, text miningPubMed
42773934PubTator, text miningPubMed
42763538PubTator, text miningPubMed
42762512PubTator, text miningPubMed
42757976PubTator, text miningPubMed
42755554PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license